decisionhealth Newsletters, Answer Books - 2007 Issue 9 (September)
Medicare_Benefit_Policy_Manual / Chapter_15 / 50.2
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare policy for determining whether a drug or biological is usually self-administered, including the evidentiary standards contractors may consider, the scope of the exclusion, beneficiary and provider appeal considerations, and reporting or notice requirements for contractors. It is relevant to Medicare contractors, billing and compliance staff, and providers who need to understand how this coverage policy is applied and documented.
Why This Topic Matters
The guidance affects whether payment is available for certain outpatient drug claims and how contractors handle coverage determinations, notice, appeals, and reporting. Understanding the policy helps organizations recognize when a drug may fall outside the incident-to benefit category and how Medicare expects the determination process to be managed.
Article Sections
-
Policy
Overview of the self-administration exclusion and the contractor responsibility for making drug-specific determinations under Medicare policy.
-
Administered
Defines the term as used in this policy and distinguishes eligible routes of administration from other medication delivery methods.
-
Usually
Explains how Medicare interprets the term for purposes of the exclusion and describes general factors contractors may consider when evaluating use patterns.
-
Definition of Acute Condition
Provides the policy definition of an acute condition and describes the types of supporting evidence that may be used in making that assessment.
-
By the Patient
Clarifies how the term is applied at the beneficiary population level and how inpatient use and certain beneficiaries are treated in the determination.
-
Evidentiary Criteria
Lists the categories of evidence contractors may consider when evaluating or reconsidering whether a drug is usually self-administered.
-
Provider Notice of Noncovered Drugs
Addresses contractor website notice, publication of exclusion lists, timing of notice, and related local policy maintenance requirements.
-
Conferences Between Contractors
Discusses contractor medical director discussions and the independent nature of contractor determinations.
-
Beneficiary Appeals
Summarizes beneficiary appeal rights and related notice and liability considerations for denied claims under this exclusion.
-
Provider and Physician Appeals
Identifies the appeal path available to physicians accepting assignment when a denial is issued.
-
Reasonable and Necessary
Describes how contractors evaluate medical appropriateness and related service considerations within the overall coverage framework.
-
Reporting Requirements
Outlines contractor reporting obligations to CMS, the required data elements, and the format expectations for exclusion lists.
What You Will Learn
- How Medicare defines and evaluates self-administration for drugs and biologicals
- What types of administration and evidentiary factors contractors may consider
- How contractor notice, appeals, and reporting requirements relate to the exclusion
- How the policy fits within Medicare’s incident-to benefit framework
Who Should Read This
- Medicare contractors
- Medical billing and coding professionals
- Compliance staff
- Physician office administrators
- Hospital outpatient billing teams
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com